Aardvark posts Phase 2 results for ARD-101 in Prader-Willi SyndromeSep 8Trial updateAardvark Therapeutics, Inc.ARD-101
Aardvark to review unblinded ARD-101 data in Q3 2026 amid FDA clinical holdAug 11Quarterly updateAardvark Therapeutics, Inc.ARD-101
Sign inSign in